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Abstract
The genus Mycobacterium is diverse, ranging from slow-growing human
pathogens such as M. tuberculosis to fast-growing saprophytes such as M. smegmatis. M.
ulcerans is the causative agent of the neglected disease known as Buruli ulcer, an
emerging pathogen first described in Buruli County, Uganda. Antibiotic resistance among
Mycobacterial pathogens is growing at an alarming rate and is creating an urgent need for
novel diagnostic and therapeutic approaches. Elucidating the details of virus/host
interactions among the mycobacteria and their phages thus has the potential to affect how
we think about the role of these bacteria in both clinical and environmental settings.
Towards this end, we are analyzing the complete genome sequence of 654
mycobacteriophages isolated on Mycobacterium smegmatis mc2155. Here we report on
six novel bacteriophages from Ugandan soil, in addition to three bacteriophages isolated
from American soil, and using pairwise nucleotide identity and phamily composition of
the genomes work to elucidate the genomic determinants for their ability or inability to
infect clinically relevant Mycobacteria, including M. ulcerans and M. tuberculosis.
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INTRODUCTION
I. Significance
Buruli Ulcer
Buruli ulcer, a disease caused by Mycobacterium ulcerans, is now considered a
neglected tropical disease by the World Health Organization (WHO) and is resulting in
significant economic and social impact (Hamzat & Boakye-Afram, 2011; World Health
Organization, 2012a). This disease leads to large skin lesions that are generally found on
the arms and legs of patients. Before the ulcerative stage of the infection a painless
nodule appears. The ulcerative stage leads to still painless lesions that may reach the
bone. The recommended treatment is a long-term combination of antibiotics including
floroquinolones and rifampicin as well as surgical debridement and grafting (O'Brien et
al., 2012). While these treatments have been reasonably successful in the treatment of
Buruli ulcer they are not always feasible, due primarily to the fact that Buruli ulcer is
most prevalent in poor and rural communities in Africa and Latin America. Early
diagnosis is important to successful treatment with antibiotics, but because of the rural
location of most patients antibiotics are often not accessible early enough, if at all. In
areas most affected by Buruli ulcer, etiology is also often attributed to mystical causes,
leading individuals first to seek traditional healers, and then medical treatment when it is
too late, leaving disfiguring surgery as the only option (Peeters Grietens et al., 2012).
Treatment is also often avoided due to the reputation of the surgery causing greater
complications than the disease itself.
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M. ulcerans pathogenesis is still unclear, making diagnosis of Buruli ulcer
difficult (World Health Organization, 2012a). In addition to difficulty in treatment Buruli
ulcer remains difficult to diagnose early. In addition the painless lesions, and
disfigurement associated with treatment result in Due to M. ulcerans slow doubling time,
culturing the bacteria takes six to eight weeks. While PCR remains the gold standard for
diagnosis, it remains difficult due to the high cost, reliance on trained professionals, and
availability of laboratory equipment.
Mycobacterium Tuberculosis and Leperae
In addition to M. ulcerans, the genus Mycobacterium also includes
Mycobacterium tuberculosis and Mycobacterium leprae. According to the WHO, in 2012
there were an estimated 8.7 million new cases of tuberculosis, leading to 1.4 million
deaths (World Health Organization, 2012b). M. leprae has been characterized as having
an intracellular lifestyle, infecting macrophages, and Schwann cells of neurons (Bhat &
Prakash, 2012). M. tuberculosis also resides within macrophages of the alveoli of the
lung; within these cells fusion of the phagosome with the lysosome is inhibited, inhibiting
lysis and allowing the pathogen to evade the immune system and persist within the cell
(Wong, Chao, & Av-Gay, 2012). One way in which M. tuberculosis and M. leprae
become intracellular is through the use of complement receptors and mannose receptors
to mediate their entry into macrophages (Van der Werf, Van der Graaf, Tappero, &
Asiedu, 1999). This intracellular lifestyle makes access to the bacteria difficult in
treatment.
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Mycobacterium ulcerans
While M. tuberculosis and M. leprae are intracellular pathogens, M. ulcerans is an
extracellular pathogen (Yeboah-Manu et al., 2006). M. ulcerans has been shown to live
an extracellular life due to the loss of the ESX-1 protein secretion system, and
antiphagocytic properties of mycolactone (the toxin secreted by M. ulcerans) (Stinear et
al., 2007a). This means that the bacteria can be more easily accessed for treatment.
The genomes of clinical isolates have been sequenced revealing that M. ulcerans
consists of a 5632 kb circular chromosome and a plasmid pMUM001 that is 174 kb. The
plasmid has a G+C content of 62.5% and contains 81 protein coding sequences (Stinear
et al., 2007b). Comparative genomics has shown that M. ulcerans likely evolved over a
million years ago from the fish pathogen progenitor M. marinum, having 98% nucleotide
similarity (Stinear, Jenkin, Johnson, & Davies, 2000). Further analysis has shown that
divergence likely occurred with the acquisition of the pUMUM001 plasmid encoding for
a mycolactone that is responsible for the phenotypic differences from M. marinum (Doig
et al., 2012). Mycolactone is the immunosuppressive polyketide toxin that is responsible
for the pathogenesis associated with infection with M. ulcerans, and is believed to have
given M. ulcerans the ability to cause this global neglected disease, Buruli ulcer (George,
Barker, Welty, & Small, 1998).
Mycobacteriophages
Bacteriophages are viruses that infect bacteria, and are estimated to be the most
abundant biological entities on planet earth with an estimated 1031 particles globally
(Wommack & Colwell, 2000). After infection of a host cell, the bacteriophage may
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undergo one of two lifestyles. In the lytic cycle replication begins immediately upon
infection of the cell, leading to rapid lysis of the bacterial host. Alternatively, in the
lysogenic cycle bacteriophages may integrate into the host genome and persist for
generations before beginning active replication and lysis of the host cell, this is believed
to be primarily due to the state of the bacterial cell but the clear mechanism is not yet
defined.
Mycobacteriophages specifically are viruses that infect mycobacterial hosts.
Currently there are 654 completely sequenced Mycobacteriophage genomes, each of
which was isolated using the non-pathogenic Mycobacterium smegmatis as a host (Henry
et al., 2010). This work has been largely due to the SEA-PHAGES program, a course
sponsored by the Howard Hughes Medical Institute (HHMI) to help encourage
undergraduate involvement in research (Hatful et al., 2006). Sequenced and annotated
genomes have been compiled into a single database allowing for bioinformatic analysis.
Effective bioinformatic tools are becoming more important due to the improvements in
technology making sequencing more efficient and cost effective. Even as the number of
sequenced mycobacteriophage genomes increases, the data continue to reveal a higher
than estimated diversity, as well as “mosaic” genome structure (Pedulla et al., 2003).
Phamerator, a bioinformatic software application, uses pairwise comparisons to
sort protein-coding genes into “phamilies” of related sequence (Cresawn et al., 2011).
Creation of genome maps allows for visualization of relatedness between phages, as well
as analysis of different evolutionary histories of individual genes of these mosaic
genomes. Using Phamerator, the mycobacteriophage genomes within the current database
can be divided into clusters. A cluster is defined based on the average pairwise nucleotide
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identity and protein family composition. Currently Mycobacteriophages are divided in to
18 clusters, given alphabetic designation, and further divided in to 28 subclusters, noted
by a numeric designation. Phages within a specified cluster have highly conserved
genomes, whereas when comparing phages between clusters there may be little similarity
(Figure 1.). Bioinformatic analysis can be utilized to gain further understanding of the
mechanisms behind host restriction in M. ulcerans. Even among phages from the same
subcluster, gene content and host range phenotypes vary considerably. While the genetic
basis of host range remains unclear, a correlative study of gene content and host range is
a first step toward identifying causal relationships.
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Figure 1. Phages within a cluster are closely related, while phages in two different clusters have little or no recognizable similarity. Phages
D29 and L5 represent phages from subcluster A2. Containing many similarities as denoted by the colors between the genome maps. Phages
BPs and Halo are both cluster G phages and as noted by the purple showing the highest level of conservation. While both cluster A and both
cluster G phage are closely related within their respective clusters, conservation is not observed between cluster A and G. (Colors between
maps represent level of similarity with the no similarity is shown by white while lowest is red, followed by orange, yellow, green, blue, indigo,
and violet being the greatest following the colors of the rainbow)
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Phage Therapy
Phage therapy, or the use of bacteriophages in the treatment of bacterial infections
is not a new idea, and may hold immense potential with the threat of a post-antibiotic era.
In the early 1900s, Felix d’Herelle and Fredrick Twort independently discovered
bacteriophages. Felix d’Herelle immediately recognized their potential, and soon after
their discovery bacteriophages were used to treat dysentery, cholera, bubonic plague and
staphylococcus skin infections (Summers, 1999). Many of these early trials have received
much criticism from the west due to their lack of documentation or credibility. In
addition, by the mid 1900’s and the emergence of antibiotics, the idea was abandoned by
the Western medicine.
While the Western world has turned away from phage therapy, its use has
continued in Eastern European and former Soviet Union countries. The Eliava institute of
Tbilisi, Georgia is known as one of the leaders in phage therapy having continually used
phage therapy in the clinic since the 1900s (http://www.eliava-institute.org). Although
phage therapy is not being used in the most traditional sense in the Western world,
several companies are using bacteriophage preparations in other novel ways including
preparations that have been approved by the FDA for the treatment of surfaces in food
processing facilities (http://www.intralytix.com). Additionally, bacteriophages are being
explored in diagnostics, especially in very-slow growing or difficult to culture bacterial
strains.
Several aspects of bacteriophages make them attractive therapeutic use, including
the fact that they are highly host-specific (minimizing damage to the normal flora of the
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host), they are self-limiting in that they require their specific bacterial host to replicate,
and they are able to replicate at the site of infection due to the presence of the specific
host (Clark & March, 2006). M. ulcerans has demonstrated resistance to antibiotics
including rifampicin, and while in the future resistance to bacteriophages could also be
observed, there are an estimated 1031 bacteriophage particles globally (Wommack &
Colwell, 2000). Mixed populations of mycobacteriophages that infect M. ulcerans could
be used, offering a potentially large number of combinations for therapy. The need for an
affordable and accessible novel treatment of M. ulcerans is great and due to its localized
infection, extracellular life cycle, and poor response to current treatments, bacteriophage
therapy could be feasible.
II Host Restriction in Bacteriophage Infection
Current Data
While genomic data for mycobacteriophages are increasing dramatically, host
range information is still limited. The only research currently published pertaining to M.
ulcerans host rang evaluated this host’s capacity to support replication of fourteen
Mycobacteriophages. Four of which infected M. ulcerans (Rybniker J,Kramme S., Small
P.L., 2005). Of these four bacteriophages, three were from cluster A, with bacteriophages
D29 and L5 belonging to cluster A2 and bacteriophage Bxz2 belonging to cluster A3. The
fourth phage, TM4, belongs to cluster K2. All four bacteriophages also demonstrated the
ability to infect two different strains of M. tuberculosis. While phages from cluster A
appear to have an advantage in infecting M. ulcerans, it is important that additional
phages from cluster A, as well as other clusters are further explored, as it is clear that host
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range can differ significantly at even the sub cluster designation. This will help gain a
greater insight to weather some specific clusters actually infect M. ulcerans more readily
than others. In a second host range paper by Deborah Jacobs-Sera et.al, phages that are
able to infect M. tuberculosis were investigated, finding that cluster K and subcluster A2
and A3 appear to most readily infect M. tuberculosis (Jacobs-Sera et al., 2012). Phages
utilized in this study are included in the Mycobacteriophage database accessed by
Phamerator. Results also indicate that host restriction is likely through single residue
substitutions in tail proteins (Jacobs-Sera et al., 2012). Phages from cluster A2, A3, K and
G all show an ability to infect the genus Mycobacterium. While the viral particles
viewed with a transmission electron microscope are similar, the gene content is highly
varied. Both of these papers indicate a potential correlation between cluster and host
range restriction in the genus Mycobacterium. Furthermore. We propose a study of a
broad phage collection like Jacobs-Sera using the host M. ulcerans.
Host restriction at Adsorption
The first step of infection by a bacteriophage is attachment to the host cell, also
known as adsorption. This attachment of the phage receptor binding protein is imperative
for subsequent injection of the viral DNA into the host therefore, attachment is believed
to be one of the largest determinants in bacteriophage infection (Henry & Debarbieux,
2012; Moldovan, Chapman-McQuiston, & Wu, 2007). In one Escherichia coli
bacteriophage, adaption to new phage binding receptors has been observed,
demonstrating that when a primary receptor is not available, the bacteriophage is able to
target a secondary receptor on the cell (Meyer et al., 2012). We therefore propose that
host restriction in M. ulcerans may be primarily due to differences between the tail fibers
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of mycobacteriophages. The Mycobacterial cell membrane of gram-negative bacteria
contains a high level of various lipids. Cell membrane content not only differs between
genera, but also by species. One example of this is arabinogalactan (AG), a lipid specific
to Mycobacteria. Slow growing mycobacteria also contain the phthiocerol lipid family,
which is not observed in fast-growing Mycobacteria (Guenin-Mace, Simeone, &
Demangle, 2009). One study demonstrated the importance of glycolipid molecules for
attachment of phage in M. smegmatis, predicting that phage binding capacity could be to
strain-specific glycolipid antigens (Khoo et al., 1996). In addition, the unique
mycolactone expressed in M.ulcerans could potentially play a similar role in host
restriction. The host range could be limited, not only by the specificity of these receptors,
but also by mutation in the tail fibers, which could prevent binding, and therefore
subsequent productive infection.
Host Restriction of Infection
Host restriction is not only observed in the initial adsorption stage, but also during
the stages of infection through various bacterial defense methods including Clustered,
Regularly Interspaced Short Palindromic Repeats (CRISPRs), toxin anti-toxin systems
and restriction endonucleases. Host restriction has been observed where Clustered
Regularly Interspaced Short Palindromic Repeats CRISPRs are present. These systems
offer a horizontally-acquired, but heritable “adaptive” immunity for bacteria and are
composed of CRISPR loci and CRISPR associated or cas genes (Richter, Chang, &
Fineran, 2012). In this system the CRISPR loci contain short non-repetitive DNA
stretches that were likely derived from the invading bacteriophage genome. This allows
for the recognition of the invading bacteriophages and subsequent sequence-specific
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cleavage of the bacteriophage DNA (Deveau et al., 2008). While CRISPR systems have
been shown to play a powerful role as the bacterial defense, this is not likely to contribute
to host restriction in M. ulcerans due to the fact that no defined CRISPR or CRISPR
associated (Cas) Systems have been identified in this host.
Toxin-antitoxin systems could play a potential role in host restriction. In these
systems, toxins are produced along with antitoxins that are capable of neutralizing the
toxin in normal situations. When the cell undergoes stress, such as infection by a phage,
the antitoxin can readily degrade. Upon degradation the toxin accumulates and acts to
induce cell death (Yamaguchi, Park, & Inouye, 2011). These systems have been identified
in systems in which a plasmid relies on the constant production of an anti-toxin, if
production of the anti-toxin stops the cell may then die due to accumulation of the toxin
without the complementary anti-toxin therefore stabilizing the plasmid in the cell
(Frampton, Aggio, Villas-Boas, Arcus, & Cook, 2012). While these systems could
effectively restrict host range, it is at the population level rather than conferring a benefit
to an individual cell. This leads us to ask the question: is the cost of phage infection
higher than death of an individual cell? While more than 60 toxin-antitoxin systems have
been identified in M. tuberculosis, there are not any currently identified in M. ulcerans.
Other possible means of host restriction include restriction endonucleases.
Restriction endonuclease systems are commonly observed in bacteria and are able to
restrict the host range by targeting and cleaving specific sequences with the invading
bacteriophage genome, terminating the infection of the host (Bickle & Kruger, 1993).
Bacteriophages are not likely contain restriction sites specific to their bacterial host,
making them less prone to cleavage by bacterial endonucleases and giving them an
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advantage in infecting that specific bacterium (Kruger & Bickle, 1983). Several potential
restriction endonuclease-like proteins have been identified within the M. ulcerans
genome (Stinear et al., 2007a). These restriction enzymes could potentially target specific
sequences in phage DNA for degradation before they are able to replicate within the cell.
While this system of restriction may be observed in M. ulcerans enzymes
involved are not well characterized and are not believed to play a large role in host
restriction.
III Specific Aims
This research aims to add to the current host range data available for
mycobacteriophages, specifically for the host M. ulcerans. This was achieved by first
identifying novel phages that have the ability to infect M. ulcerans. These novel phages
were isolated from soil using a mycobacterium lab strain Mycobacterium smegmatis
(mc2155) and then tested using the M. ulcerans host. A second aim was to sequence and
annotate a portion of novel phages using next generation sequencing techniques and
annotation tools. The final aim was to use bioinformatics to further define host range in
M. ulcerans. In addition to the novel environmental isolates, other mycobacteriophages
from various geographical regions as well as other mycobacteriophages that have already
been sequenced were also obtained and used for testing on the M. ulcerans host.
We propose that bioinformatic comparisons can be used to predict host range
phenotypes of mycobacteriophages. By comparison of the two subsets of gene content
data for bacteriophages with a phenotype able to infect vs. unable to infect the host within
a single sub cluster, individual tail protein families are predicted to cluster according to
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host range. Identification of point mutations within these tail fiber proteins can be further
investigated in the lab by restoring mutations, thereby restoring the ability of that phage
to infect M. ulcerans. A genome wide-association approach was used to investigate
further conservation within phages that are able to infect M. ulcerans. Using
bioinformatics to guide further laboratory investigation, we aim to develop an increased
understanding of M. ulcerans host range, allowing for the incorporation of host range
predictions into bioinformatic tools like Phamerator.

METHODS
Bacterial Strains
Two M. ulcerans strains were obtained as a gracious gift from Pamela Small
(University of Tennessee). M. ulcerans 1615 is a pathogenic clinical isolate from a
Malaysian patient (American Type Culture Collection 35840), and M. ulcerans 118 is a
derivative that is lacking in the pMUM001 virulence plasmid (Stinear et al., 2004). Both
M. ulcerans strains were grown at 30° C for 1-3 months on 10% OADC enriched
Middlebrook 7H10 agar. Liquid cultures were made by passaging cells from plates in
10% OADC enriched Middlebrook 7H9 media and incubated at 30° C while shaking at
50 RPM for 1-2 weeks. Mycobacterium smegmatis mc2155 (Snapper, Melton, Mustafa,
Kieser, & Jacobs, 1990) was used for isolation of novel phages. M. smegmatis was grown
on Middlebrook 7H10 agar 10% ADC, at 37° C shaking at 250 rpm for 24-48 hours.
Carbenicillin (50 g/ml) and cycloheximide (10 g/ml) were added to all media.
Bacteriophages
All novel bacteriophages were isolated by enrichment of soil samples with M.
smegmatis for 24 hours before plating on top agar overlays as described below. Putative
plaques were then selected and subjected to repeated plaque purification through a series
of plating until plaque morphology indicates a single phage population. All
mycobacteriophages were propagated using M. smegmatis to generate high titer lysates.
This was achieved by seeding top agar overlays with 500 l M. smegmatis and plating
bacteriophages diluted in phage buffer (10 mM Tris-HCl, pH 7.5; 10 mM MgSO4; 68.5
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mM NaCl; 1 mM CaCl2). Lysates were collected by flooding, collecting, and filtering
phage buffer from high titer plates.
Amplification Assay
To rapidly identify phages that have the ability to infect the M. ulcerans host, a
phage amplification assay was preformed as outlined by Small (Rybniker J,Kramme S.,
Small P.L., 2005). Phages tested included unsequenced novel phages as well as a
collection of previously sequenced phages obtained as a generous gift from Graham
Hatfull (University of Pittsburgh). D29 was used as a positive control bacteriophage
capable of infecting M. ulcerans (Rybniker J,Kramme S., Small P.L., 2005). The
amplification assay was preformed by adding 50l of each phage tested to 50l of
bacterial culture at an OD of 0.6. Each phage was diluted such that the final concentration
in the infection was 107 pfu/ml, establishing a multiplicity of infection (MOI) of 1.
Infection was allowed to take place at 30° C for 90 min (Giri, Bhowmik, Bhattacharya,
Mitra, & Das Gupta, 2009). After infection exogenous phage particles were deactivated
using 2 mM ferrous ammonium sulfate (FAS) as previously described (McNerney et al.,
1998). After vigorous vortexing and incubation at room temperature for 5 min, 20l of
each amplification product was plated on top agar overlays seeded with 500 l M.
smegmatis and incubated for 24 hrs at 37° C.
DNA Sequencing
Genomic DNA was prepared for next generation sequencing by first obtaining 10
ml of high titer lysate prepared by infecting lawns of M. smegmatis and incubating at 37°
C for 24 hours. The plates were flooded with phage buffer and allowed to further
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incubate overnight at 4°C. Bacteriophage particles were then filtered through a 0.22 μm
filter to remove any bacterial cells. DNAse was then added to degrade any bacterial
DNA. After incubation with DNAse at 37° C phage particles were separated from the
mixture using polyethylene glycol precipitation and centrifugation. Bacteriophages were
then resuspended in buffer and the DNA was extracted using guanidinium thiocyanate
and syringe-mounted columns (Promega Wizard® Genomic DNA Purification Kit.).
Genomic DNA was quantified using a standard fluorometer assay.
A bar-coded 200 bp DNA library was then prepared using enzymatic shearing
(IonXpressTM Plus gDNA Fragment Library Preparation kit). Appropriate sized fragments
were size selected using the E-Gel® SizeSelectTM Agarose Gel. The sample libraries were
equalized using the Ion Library EqualizerTM Kit before templating and sequencing. This
was achieved using the Ion torrent Personal Genome Machine (PGM) with an Ion 314TM
chip, and the Ion PGMTM Template OT2 200 templating and sequencing kits.
Bioinformatics
Genomic sequence was assembled using the GS de Novo assembler. After the
genomes were assembled they were annotated using gene prediction and annotation
software including DNA Master, GeneMark, and Gene Locator and Interpolated Markov
ModelER (GLIMMER). These genomes were then added to the existing Mycobacterium
database in Phamerator. This was achieved by assigning protein families to each gene
using nucleotide blast alignments with an evalue threshold of 1 x 10-5. Proteins with no
database matches are assigned a new protein family and are considered “orphams”.

RESULTS
Isolation of novel bacteriophages
Six novel mycobacteriophages were isolated from soil samples obtained from
Ugandan soil taken from three locations in Gulu, Uganda (GPS coordinates 2.788194,
32.305600, 2.788194, 32.305637 and 2.775200, 32.290647) (figure 2). The names
given to these bacteriophages are Espe, Naomi, Gloria, Mercy, Fatuma and Aloyo. All
phages produced clear plaques on M. smegmatis (Figure 3).

Figure 2. Map of Uganda showing were soil samples were collected (Red pin), in relation to
Buruli county Uganda (Blue pin) where Buruil ulcer was first identified.
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Figure 3. Plaque assay of Espe showing the large clear plaques plated on M. smegmatis
mc2155 (shown by the arrow). Naomi, Gloria, Mercy, Fatuma and Aloyo also produced clear
plaques of similar sizes.

In addition four other phages were isolated from soil from Harrisonburg,
Virginia through collaboration with undergraduate students. These phages also
isolated on M. smegmatis mc2155 were named Lauren 3(1),Burke, OrionPax and
Rover14. OrionPax produced halo-like plaques, while Lauren 3(1), Burke and
Rover14 all produced clear plaques similar to those of the phages isolated from the
Ugandan soil.
Optimization of the Amplification Assay:
Pathogenic and non-pathogenic M. ulcerans strains were first plated on 7H9
with 10% OADC before suspensions were made for use in the assay. Inoculation of
liquid media was not effective in growth of liquid cultures (Figure 4). In order to
obtain liquid cultures with an optical density of 0.6, suspensions of M. ulcerans 118
cells were made by passaging of cells through a 25 gauge needle (figure5).
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Figure 4. M. ulcerans liquid culture grown for one year at 30° C. Shaking at 50 RPM. Cell
growth produces colonies that adhere to the flask rather than producing a turbid culture.

Figure 5. Resuspension of M. ulcerans cells to produce a culture with an optical density of 0.6 at
600 nm. After passage of colonies grown in liquid culture through a 25 gauge needle, the culture
is turbid as compared to the culture shown above.
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Elimination of exogenous phages with ferrous ammonium sulfate (FAS) at a
molarity of 2 mM was shown effective using M. smegmatis mc2155 and D29. Infections
with a ratio of one bacterial cell to one bacteriophage, or an MOI of one were used, and
infection proceeded for 100min. When no bacterial cells were are added, all phages were
successfully eliminated, while when bacterial cells were added successful infection
occurred on the indicator plate. When no FAS was added initial added, as well as those
produced by infection are plated on the indicator plate (figure 6).

Figure 6. Elimination of exogenous phage particles with 2mM FAS and a MOI: 1 with D29.
Top row: M. smegmatis mc2155- D29+ FAS+. Middle row: M. smegmatis mc2155+ D29+ FAS+
(6-fold dilutions from left to right) Bottom row: M. smegmatis mc2155 + D29+ FAS- (6-fold
dilutions as shown above).
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Control amplification assays were preformed with D29 and Rosebush, both
isolated and able to infect M. smegmatis mc2155. D29 was also used as a positive
control in the M. ulcerans 118 strain while Rosebush was used as a negative control
for M. ulerans 118 as described by Pam Small (Figure 7 & 8). It should be noted that
in the M. smegmatis mc2155 plate the amplification product ran, resulting in the
smeared appearance, as compared to the spots typically seen. Infections were at a
MOI of one and allowed to precede for 100 min before deactivation with 2 mM FAS.

Figure 7. Amplification assay with M. ulcerans118, 2mM FAS, MOI: 1 and 100 min infection
time. Top row: Negative control Rosebush, Left: M. ulcerans 118 and Rosebush + no FAS,
middle: M. ulcerans 118 – Rosebush + FAS +, Right M. ulcerans 118 and Rosebush + FAS +.
Bottom row: same as above with positive control bacteriophage D29.
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Figure 8. Amplification assay with M. smegmatis mc2155, 2mM FAS, MOI:1 and 100 min
infection time. Top row: Negative control Rosebush, Left: M. smegmatis mc2155 and Rosebush +
no FAS, middle: M. smegmatis mc2155– Rosebush + FAS +, Right M. smegmatis mc2155 and
Rosebush + FAS +. Bottom row: same as above with positive control bacteriophage D29.

Sequence of novel bacteriophages
Genomic DNA was isolated from Espe, Naomi, OrionPax, Rover14 and Burke.
The concentration of the genomic DNA was then calculated using a standard
fluorometer. Espe had a concentration of 114.97 ng/μl, Naomi 14.70 ng/μl, OrionPax
276.50 ng/μl, Rover14 302.83 ng/μl and Burke 139.45 ng/μl.
After creation of the 200bp library by enzymatic shearing the individual
libraries were pooled together for templating and enrichment. The final template
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library concentration as calculated using the qubit ion sphere quality control kit was
3.31%. The library was then run on two 314 ion chips.
The first run produced 183,217 total sequencing reads with a mean length of
216 base pairs. Ion sphere particles (ISP) were loaded in to 39% of the wells on the
314 ion chip with 80% enrichment and 86% clonal spheres (Figure 9). Of the total
reads, 26,273 corresponded to the Espe genome, 9,296 to Rover14, 22,388 to Burke
and 123,994 to OrionPax (figure 10). In the second run 114,859 total reads were
sequenced with a mean length of 188 base pairs. 25% of the wells on the second 314
ion chip were loaded with ISP’s with a 79% enrichment and 86% clonal spheres. In
this run 16,211 sequencing reads corresponded to the Espe genome, 6,105 to
Rover14, 13,853 to Burke and 77,818 to OrionPax.
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Figure 9. Loading metrics from the Ion Torrent PGM for the first run of Espe, Rover14, Burke and OrionPax. Ion Sphere Particle (ISP) loading density of the 314 chip is
shown on the left where blue indicates a low ISP density and red indicating the highest ISP density. Center panel shows information regarding the ISPs and weather they
were usable in the final library. Right panel shows average read length.
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Figure 10. Sample-specific metrics retrieved by barcode for run one on the Ion Torrent PGM of Espe, Rover14, Burke and OrionPax. For each sample the
number of bases sequenced, quality bases sequenced, reads sequenced and the mean length of those reads is shown.
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Figure 11. Loading metrics from the Ion Torrent PGM for the second run of Espe, Rover14, Burke and OrionPax. Ion Sphere Particle (ISP) loading
density of the 314 chip is shown on the left where blue indicates a low ISP density and red indicating the highest ISP density. Center panel shows
information regarding the ISPs and weather they were usable in the final library. Right panel shows average read length.
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Figure 12. Sample specific metrics for run two on the Ion Torrent PGM of Espe, Rover14, Burke and OrionPax. For each sample the
number of bases sequenced, quality bases sequenced, reads sequenced and the mean length of those reads is shown.
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Each genome was assembled using the GS de Novo assembler. Espe, OrionPax
and Rover14 each assembled in to a single contig of 51,099 base pairs, 75,059 base pairs
and 41,440 base pairs respectively. Burke assembled into four contigs of 134,463 base
pairs, 13,599 base pairs, 4,355 base pairs and 2,680 base pairs.
The average depth of coverage for each of the genomes was then calculated.
OrionPax had the greatest depth of coverage with 526, while Espe had an average depth
of coverage of 158 and Rover14 had an average depth of coverage of 65.

Bioinformatic Analysis
Annotations were completed for Espe and OrionPax. The Espe genome was
determined to have GC content of 63.85% and 100 genes. Twenty of these genes were
assigned putative functions based on BLAST, HHpred, and RPS-BLAST searches. This
genome belongs to the mycobacteriophage cluster A1.
OrionPax has a GC content of 63% and 143 genes, with 30 where function could
be assigned. OrionPax belongs to the mycobacteriophage cluster E.
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Figure 13. Phamerator genome maps for Espe and OrionPax. The left end of each genome is shown. Genes are displayed as colored boxes
above and below the ruler, forward transcribed above and reverse below. Color indicates conserved protein phamilies.

DISCUSSION
Isolation of novel Bacteriophages
While not all of the novel phages isolated have been sequenced, the five
unsequenced phages have been archived for use in subsequent experiments and will
be tested on the M. ulcerans host. These phages are particularly valuable because
they were isolated from Gulu Uganda, which is near where Buruli ulcer was first
identified and is still endemic.
Amplification assay
Due to several factors, the amplification assay method to test bacteriophages on
M. ulcerans has proven to be more difficult than expected, and has not given reproducible
results for most tested phages. One limitation of this method is the host its self. M.
ulcerans is notoriously difficult to culture, and our experiences are consistent with this.
With a doubling time of 30-80 hours it is a very slow growing organism. In addition to
the slow growth, cells also tend to clump significantly in liquid cultures (figure 4) making
it difficult to obtain a turbid culture. In order to circumvent some of these difficulties we
were able to create liquid cultures by suspending cells grown on a plate. We found that
passing cells through a 25-gauge needle repeatedly, in new media, significantly reduced
clumping and allowed for a liquid culture with an optical density of 0.6 at 600 nm to be
achieved (figure 5).
Elimination of exogenous phage particles is important to ensure that the phages
seen on the indicator plate are from active infection of the pathogenic bacteria and not
from the initial infection. In order to eliminate exogenous bacteriophages, FAS was used
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at a molarity of 2 mM as previously described. We have found that elimination of
bacteriophages with FAS can be inconsistent and sometimes insufficient at 2 mM when
infecting at a multiplicity of infection of 1. We have also noted that elimination with FAS
may vary depending on the bacteriophage itself. As the mechanism behind inactivation
with FAS is unknown it is difficult to determine why effectiveness could vary.
A third variable is the time that infection is allowed to proceed. It has been
previously reported that temperature has the ability to effect the time taken from
attachment to lysis of the bacterial cell. Time points of 40 min and 100 min were
routinely used in our assay. Inconsistencies in results have made it difficult to determine
if the bacteriophage particles plated were due to amplification (lysis) of the bacterial host
or plating of bacterial cells that have been infected. This hinders the ability of this test to
be used in a quantifiable manner.
Phage amplification still holds potential for testing many bacteriophages on the
M. ulcerans host. Although results have been inconsistent, the positive control
(mycobacteriophage D29) and negative control (mycobacteriophage Rosebush) have
been successful multiple times (figure 7 & 8).
Sequencing
Here we report on the first sequence produced on the ion torrent PGM at James
Madison University. Of the four phages sequenced in the first two runs, Espe and IronPax
were completely finished and annotated using the PGM sequence alone. Rover14
assembled into a single contig, but due to the fact that the average depth of coverage was
only 65, some areas contain low quality consensus sequence. In order to complete this
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genome, primers have been designed for Sanger sequencing. The fourth genome Burke,
assembled in to four contigs. After evaluation of each of the four contigs it appears that
Burke belongs to the mycobacteriophage cluster C. Cluster C phages are relatively large
compared to other phages with an average genome size of 155,504 base pairs. Due to the
ISP loading densities being low for both runs (figure 9 & 11), and low final template
library concentration with only 3.31% templated we were not able to generate
enough depth of coverage to obtain a quality consensus sequence for the entire
genome with an average depth of coverage of 44 reads.
When finishing the genomes it was also noted that strand specific insertions
and deletions were common in all genomes. This strand bias has been noted in many
ion torrent sequencing applications, but it has yet to be explained (Quail et al., 2012).
Bioinformatics
Mycobacteriophages are known for their mosaic and diverse genomes. Here we
report on the complete genome sequencing and annotation of two novel
mycobacteriophages: Espe and OrionPax. Using pairwise nucleotide alignment and gene
content analysis, Espe was determined to belong to the A1 subcluster of
mycobacteriophages. This genome contains one novel gene, which is the basis for a new
“orpham.” When comparing Espe to phages of cluster A, a number of sequence repeats
were observed. These are consistent in terms of their genomic locations (near 21,000,
41,000, and 47,000 base pairs) with “stoperators,” sequences that act in cis to regulate
transcriptional elongation. OrionPax belongs to cluster E. There were no orphams
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identified in this genome. This is typical for cluster E phages as they are highly conserved
at the nucleotide and protein level.
Summary
Some cluster A, K, and G phages isolated on M. smegmatis have since been
shown to infect M. tuberculosis or M. ulcerans (Jacobs-Sera et al., 2012; Rybniker
J,Kramme S., Small P.L., 2005). There is a strong correlation between phage sub cluster
and the ability to infect these alternative hosts, however this correlation is not absolute.
Cluster A is large and diverse, with eleven sub clusters in the current database. Genomes
within the same sub cluster are more closely related to one another than to genomes
withith a different sub cluster of cluster A. However, when comparing protein
conservation within cluster A phages a much greater level of conservation is seen at both
cluster and sub cluster designations.
Previous data suggest that the set of phages that can replicate on M. ulcerans is
very similar to that for M. tuberculosis. However, we have found this not to be the case.
Within cluster A, several bacteriophages from sub clusters A2 and A3 have the ability to
infect M. tuberculosis and M. ulcerans. Two additional phages from the A1 cluster, Bxb1
and U2, have also shown a limited ability to infect M. tuberculosis. Espe belongs to the
A1 sub cluster. When comparing genomic data and preliminary amplification assay data
for Espe, we propose that this bacteriophage may also be able to infect M. ulcerans.
When using Phamerator maps for comparisons of Espe, Bxb1 and U2 a high level of
conservation is observed at the protein level, especially between Espe and Bxb1. In
addition, the highest level of conservation at both the nucleotide and protein level is
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observed in the region where tail fiber proteins are predicted (Figure 14). KSSJEB,
belonging to the A1 sub cluster has not previously been shown to infect mycobacterial
hosts. This is also consistent with the preliminary data that we have obtained using the
amplification assay.
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Figure 14. Conservation in the left arm of Bxb1, Espe and U2, three cluster A1 phages. Genes shown by
boxes above the ruler are translated in the forward direction. Shading between genomes shows nucleotide
conservation (purple being the highest degree of conservation followed by indigo, blue, green, yellow,
orange and red being the lowest). Protein conservation is shown by the color of the boxes. Each protein
family is assigned a unique identifying color. The box shows area of predicted tail fiber function.
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Although final annotations have not been completed for Rover14, we predict that
this bacteriophage will have the ability to infect M. ulcerans due to preliminary data from
the amplification assay and that all previously tested cluster G phages have been able to
infect pathogenic mycobacterial hosts. While the OrionPax genome was completely
finished, host range data is limited for cluster E phages.
Mycobacterial infections pose a serious health threat globally, and have a
serious impact in many middle to low income countries. Here we propose that
bacteriophages could offer an affordable and effective tool in combating these serious
diseases. Not only do bacteriophages provide potential as a traditional therapeutic,
but also could play an important role in the diagnosis of these slow-growing and
difficult-to-diagnose diseases. In the case of Buruli ulcer the potential of a topical
treatment could provide a unique opportunity to reintroduce phage therapy. In order
to fulfill the potential of this large, diverse and dynamic population, investigation of
host restriction and functionality of proteins in bacteriophage genomes must be
completed. We hope that the amplification assay coupled with genomic analysis will
help to elucidate these complex virus/host interactions.
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